NEW YORK--(BUSINESS WIRE)--PrecisionMD, the developer of innovative therapeutic and cosmetic skincare solutions, reveals the impressive results of a new study showing that its Vivatia Brightening Complex containing two percent hydroquinone (HQ), is as effective for reducing skin pigmentation as a four percent HQ formulation. For consumers this means fast, dramatic results at a lower percentage of hydroquinone.
“The secret is in the first-ever proprietary foam technology system previously only available in prescription skin care products” Jeffrey Nugent, Chief Executive Officer at PrecisionMD, said. “The products deliver highly concentrated levels and unique combinations of anti-aging ingredients while minimizing irritation, improving absorption and hydrating the skin.” Hydroquinone typically fights with other brightening ingredients making it difficult to formulate, but PrecisionMD’s foam technology found a way to solve this problem. The Vivatia foam enables two percent hydroquinone to be combined with nine additional skin brightening ingredients, such as kojic acid, arbutin, licorice root and niacinamide, for visible results in as little as four weeks.
A recent blinded split face study examined 22 patients over a 12 week period of time. The study protocol had patients apply Vivatia two percent HQ twice daily to one side of the face while applying a four percent HQ product to the other side. Results were assessed at weeks four, 8 and 12 by three different independent clinicians. Based on this blinded assessment, Vivatia matched the performance of the four percent HQ at weeks four, 8 and 12 for mottled pigmentation and overall skin brightening. “With the ability to get four percent HQ results with the new Vivatia two percent HQ Foam, our patients can now use this new system year round—and that’s a big deal,” said Brian Zelickson, MD, study investigator and board-certified dermatologist in Edina, MN.
Hydroquinone has often been referred to as the gold standard of skin brightening ingredients. However, many doctors recommend the lowest level required to achieve the desired results.
Vivatia’s Brightening Complex is sold individually or as part of a three-piece kit that includes an Active Repair Complex containing 0.5 percent, 0.75 percent or 1.0 percent retinol and a Gentle Cleanser. The kit is designed to be an affordable, easy to use system that visibly improves skin tone, texture, fine lines and wrinkles while brightening the skin.
Vivatia is appropriate for all skin types and can be combined with a prescription retinoid.
Vivatia is only available through your physician. For more information or to find an authorized PrecisionMD physician in your area, please, visit www.precisionmdskin.com.
Headquartered in New York, NY, PrecisionMD is committed to developing, manufacturing and marketing innovative therapeutic and cosmetic skincare solutions that meet the dispensing needs of its physician partners and their patients. Our brands include Vivatia, Dermaceutic, Relastin, DermaChromatic and CelfixDNA. PrecisionMD is the physician direct subsidiary of Precision Dermatology, one of the fastest growing professional dermatology companies in the country. Precision Dermatology’s President, Chief Executive Officer and Founder, Jeffrey Nugent has over 25 years of dermatology and consumer skin and beauty care experience.